drugset / Trial / NCT05740202
A Trial of SHR-7367 in Subjects With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This is a dose-escalation and dose-expansion Phase 1 trial to evaluate the safety and tolerability of SHR-7367 in subjects with advanced solid tumors.
Timeline
- Start
- 2023-03-06
- Primary completion
- 2025-08-04
- Completion
- 2025-08-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SHR-7367 | Unknown | — | — |